Favorable Outcome of Intensive Treatment for Relapsed Diffuse Large B Cell Lymphoma With Secondary Central Nervous System Involvement.
Aggressive multimodal treatment substantially improved survival odds for the challenging subset of lymphoma patients with brain involvement.
This clinical trial examined Favorable Outcome of Intensive Treatment for Relapsed Diffuse Large B Cell Lymphoma With Secondary Central Nervous System Involvement. Intensive treatment may substantially improve survival in relapsed DLBCL patients with CNS involvement.
What the study was
- Study design
- Clinical trial
- Population
- Human participants or patients described in the PubMed abstract
- Category
- Other
- Maturity
- Exploratory
- Journal
- Anticancer research
Why it surfaced
Clinical trial; conservative rapid-triage score based on novelty, clinical relevance, design quality, and population or unmet need.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.